BiotechTube
Home/Greenwich LifeSciences/Dr. Sibylle Loibl
DS

Dr. Sibylle Loibl

Steering Committee Member, German Breast Group (GBG)

Greenwich LifeSciences

Therapeutic Areas

OncologyBreast Cancer

Greenwich LifeSciences Pipeline

DrugIndicationPhase
GLSI-100 (GP2 + GM-CSF)Prevention of recurrence in HLA-A*02 positive, HER2/neu positive breast cancer (adjuvant setting)Phase 3

Leadership Team at Greenwich LifeSciences

DM
Dr. Mothaffar F. Rimawi
Steering Committee Member, Baylor College of Medicine
DF
Dr. Francois-Clement Bidard
Steering Committee Member, Unicancer (France)
DW
Dr. William J. Gradishar
Steering Committee Member, Northwestern University
DM
Dr. Miguel Martin
Steering Committee Member, GEICAM (Spain)
DJ
Dr. Joyce A. O’Shaughnessy
Steering Committee Member, US Oncology
DH
Dr. Hope S. Rugo
Steering Committee Member, City of Hope
DL
Dr. Laura M. Spring
Steering Committee Member, Harvard Medical School/Dana-Farber
DC
Dr. Cesar A. Santa-Maria
Steering Committee Member, Johns Hopkins University
S
Snehal
Author/Website Contact
View full Greenwich LifeSciences profile